Madrigal Pharmaceuticals Reports Second-Quarter 2025 Financial Results and Provides Corporate Updates

Go back to Madrigal Pharmaceuticals Reports Second-Quarter 2025 Financial Results and Provides Corporate Updates
(NASDAQ: MDGL) Delayed: 542.75 +8.59 (1.61%)
Previous Close $534.16    52 Week High $18.24 
Open $529.50    52 Week Low $6.60 
Day High $546.88    P/E N/A 
Day Low $526.88    EPS $0.00 
Volume 170,546